Leflunomide-Induced Interstitial Lung Disease: A Case Report

Leflunomide (LEF) induced interstitial pneumonitis is a very rare condition but potentially fatal. We report a case of LEF induced interstitial pneumonitis. A 63-year-old woman followed-up for 37 years with the diagnosis of rheumatoid arthritis treated with LEF (20 mg/day) since 5 months were admitted to our hospital with cough, dyspnea, fever, and dark sputum.Chest radiography represented bilateral alveolar consolidation. High-resolution computed tomography demonstrated diffuse ground-glass appearance and interlobular septal thickening. Since the patient's clinics and radiologic findings improved dramatically after the cessation of LEF and recieving oral steriod therapy, she was diagnosed as drug-induced interstitial lung disease. In conclusion, when nonspecific clinical signs such as respiratory distress, cough and fever seen during the use of LEF, drug-induced interstitial lung disease should be kept in mind for the differantial diagnosis

Kaynakça

Matsuno O. Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches. Respir Res 2012; 13: 39. [CrossRef]

Chikura B, Lane S, Dawson JK. Clinical expression of leflunomide-indu- ced pneumonitis. Rheumatology (Oxford) 2009; 48: 1065-8. [CrossRef]

Emery P, Breedveld FC, Lemmel EM, Kaltwasser JP, Dawes PT, Gömör B, et al. A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology (Oxford) 2000; 39: 655-65. [CrossRef]

Behrens F, Koehm M, Burkhardt H. Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses. Curr Opin Rheumatol 2011; 23: 282-7. [CrossRef]

Kelly C. Leflunomide and the lung. Rheumatology (Oxford) 2009; 48: 1017-8. [CrossRef]

Ulusoy H, Bilgici A, Kuru O, Celenk C. Pulmonary abscess due to lefluno- mide use in rheumatoid arthritis: a case report. Rheumatol Int 2005; 25: 139-42. [CrossRef]

Carloni A, Piciucchi S, Giannakakis K, Nori G, Zobel BB, Poletti V. Diffuse alveolar hemorrhage after leflunomide therapy in a patient with rheu- matoid arthritis. J Thorac Imaging 2008; 23: 57-9. [CrossRef]

Sakai F, Noma S, Kurihara Y, Yamada H, Azuma A, Kudoh S, et al. Ichikawa leflunomide-related lung injury in patients with rheumatoid arthritis: imaging features. Mod Rheumatol 2005; 15: 173-9. [CrossRef]

Kumbasar ÖÖ, Akçay Ş, Akova M, Azap A, Çelikbaş A, Tabak L, ve ark. Türk Toraks Derneği bağışıklığı baskılanmış erişkinlerde gelişen pnömoni tanı ve tedavi uzlaşı raporu. Türk Toraks Derg 2009; 10: S1-16.

Hirabayashi Y, Shimizu H, Kobayashi N, Kudo K. Leflunomide-induced pneu- monitis in a patient with rheumatoid arthritis. Intern Med 2006; 45: 689-91. [CrossRef]

Wong SP, Chu CM, Kan CH, Tsui HS, Ng WL. Successful treatment of lef- lunomide-induced acute pneumonitis with cholestyramine wash-out therapy. J Clin Rheumatol 2009; 15: 389-92. [CrossRef]

Kaynak Göster

Solunum
  • ISSN: 1302-4922
  • Yayın Aralığı: Yılda 0 Sayı
  • Başlangıç: 2018

1.2b451